Your browser doesn't support javascript.
loading
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status.
Dora, David; Ligeti, Balazs; Kovacs, Tamas; Revisnyei, Peter; Galffy, Gabriella; Dulka, Edit; Krizsán, Dániel; Kalcsevszki, Regina; Megyesfalvi, Zsolt; Dome, Balazs; Weiss, Glen J; Lohinai, Zoltan.
Affiliation
  • Dora D; Department of Anatomy, Histology and Embryology, Semmelweis University, Budapest, Hungary.
  • Ligeti B; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary.
  • Kovacs T; Department of Anatomy, Histology and Embryology, Semmelweis University, Budapest, Hungary.
  • Revisnyei P; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Galffy G; Department of Telecommunications and Media Informatics, Budapest University of Technology and Economics, Budapest, Hungary.
  • Dulka E; County Hospital of Torokbalint, Torokbalint, Hungary.
  • Krizsán D; County Hospital of Torokbalint, Torokbalint, Hungary.
  • Kalcsevszki R; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary.
  • Megyesfalvi Z; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary.
  • Dome B; National Koranyi Institute of Pulmonology, Budapest, Hungary.
  • Weiss GJ; Department of Thoracic Surgery, National Institute of Oncology, Semmelweis University, Budapest, Hungary.
  • Lohinai Z; Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Oncoimmunology ; 12(1): 2204746, 2023.
Article in En | MEDLINE | ID: mdl-37197440
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Oncoimmunology Year: 2023 Document type: Article Affiliation country: Hungria Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Oncoimmunology Year: 2023 Document type: Article Affiliation country: Hungria Country of publication: Estados Unidos